Addex Therapeutics Future Growth
Future criteria checks 0/6
Addex Therapeutics is forecast to grow earnings and revenue by 47.2% and 0.7% per annum respectively while EPS is expected to grow by 46.4% per annum.
Key information
47.2%
Earnings growth rate
46.4%
EPS growth rate
Biotechs earnings growth | 35.4% |
Revenue growth rate | 0.7% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 28 Aug 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2 | -3 | -3 | -3 | 1 |
12/31/2025 | 1 | -5 | -3 | -3 | 2 |
12/31/2024 | 1 | -5 | -3 | -3 | 2 |
3/31/2024 | 1 | -11 | -8 | -8 | N/A |
12/31/2023 | 2 | -11 | -8 | -8 | N/A |
9/30/2023 | 2 | -9 | -10 | -10 | N/A |
6/30/2023 | 2 | -11 | -11 | -11 | N/A |
3/31/2023 | 2 | -15 | -14 | -14 | N/A |
12/31/2022 | 1 | -21 | -16 | -16 | N/A |
9/30/2022 | 1 | -22 | -16 | -16 | N/A |
6/30/2022 | 2 | -21 | -16 | -16 | N/A |
3/31/2022 | 2 | -19 | -17 | -17 | N/A |
12/31/2021 | 3 | -15 | -15 | -15 | N/A |
9/30/2021 | 5 | -13 | -11 | -11 | N/A |
6/30/2021 | 4 | -13 | -11 | -11 | N/A |
3/31/2021 | 4 | -11 | -11 | -11 | N/A |
12/31/2020 | 4 | -13 | -12 | -12 | N/A |
9/30/2020 | 3 | -14 | -13 | -13 | N/A |
6/30/2020 | 3 | -15 | -15 | -15 | N/A |
3/31/2020 | 3 | -16 | -11 | -11 | N/A |
12/31/2019 | 3 | -15 | -10 | -9 | N/A |
9/30/2019 | 2 | -13 | -10 | -10 | N/A |
6/30/2019 | 3 | -12 | -6 | -6 | N/A |
3/31/2019 | 5 | -6 | -3 | -3 | N/A |
12/31/2018 | 7 | -2 | 2 | 2 | N/A |
9/30/2018 | 6 | 0 | 2 | 2 | N/A |
6/30/2018 | 6 | 1 | 2 | 2 | N/A |
3/31/2018 | 3 | -1 | 0 | 0 | N/A |
12/31/2017 | 0 | -3 | N/A | -2 | N/A |
9/30/2017 | 0 | -3 | N/A | -2 | N/A |
6/30/2017 | 0 | -3 | N/A | -2 | N/A |
3/31/2017 | 0 | -3 | N/A | -2 | N/A |
12/31/2016 | 0 | -3 | N/A | -3 | N/A |
9/30/2016 | 1 | -3 | N/A | -3 | N/A |
6/30/2016 | 1 | -3 | N/A | -3 | N/A |
3/31/2016 | 1 | -4 | N/A | -3 | N/A |
12/31/2015 | 1 | -4 | N/A | -3 | N/A |
9/30/2015 | 1 | -4 | N/A | -2 | N/A |
6/30/2015 | 0 | -4 | N/A | -2 | N/A |
3/31/2015 | 0 | -3 | N/A | -2 | N/A |
12/31/2014 | 0 | -2 | N/A | -2 | N/A |
9/30/2014 | 0 | -2 | N/A | -4 | N/A |
6/30/2014 | N/A | -1 | N/A | -6 | N/A |
3/31/2014 | 0 | -8 | N/A | -11 | N/A |
12/31/2013 | 0 | -14 | N/A | -16 | N/A |
9/30/2013 | 0 | -20 | N/A | -20 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: APE1 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: APE1 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: APE1 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: APE1's revenue (0.7% per year) is forecast to grow slower than the German market (5.5% per year).
High Growth Revenue: APE1's revenue (0.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if APE1's Return on Equity is forecast to be high in 3 years time